Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals

Emerg Infect Dis. 2002 Jul;8(7):697-701. doi: 10.3201/eid0807.010427.

Abstract

Antimicrobial resistance is increasing in nearly all health-care-associated pathogens. We examined changes in resistance prevalence during 1996-1999 in 23 hospitals by using two statistical methods. When the traditional chi-square test of pooled mean resistance prevalence was used, most organisms appear to have increased in prevalence. However, when a more conservative test that accounts for changes within individual hospitals was used, significant increases in prevalence of resistance were consistently observed only for oxacillin-resistant Staphylococcus aureus, ciprofloxacin-resistant Pseudomonas aeruginosa, and ciprofloxacin- or ofloxacin-resistant Escherichia coli. These increases were significant only in isolates from patients outside intensive-care units (ICU). The increases seen are of concern; differences in factors present outside ICUs, such as excessive quinolone use or inadequate infection-control practices, may explain the observed trends.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Anti-Infective Agents / pharmacology
  • Bacterial Infections / drug therapy
  • Bacterial Infections / microbiology*
  • Ciprofloxacin / pharmacology
  • Cross Infection / drug therapy
  • Cross Infection / microbiology
  • Drug Resistance, Multiple, Bacterial*
  • Hospitals*
  • Humans
  • Lactams
  • Time Factors
  • United States
  • Vancomycin / pharmacology

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Lactams
  • Ciprofloxacin
  • Vancomycin